Canada Approves Insomnia Sublinox

Business News Agency August 1st Valeant International Pharmaceuticals said that Canadian regulators have approved Sublinox, its insomnia treatment drug, and it is expected to launch the product in Canada in the fourth quarter.

The Canadian Pharmacists stated that Sublinox is a tablet designed to provide short-term treatment of insomnia and relieve its symptoms. Insomnia manifests itself as difficulty falling asleep and frequent nighttime or early awakening in the morning.

Sublinox will be sold by a joint venture between Valeant and Meda AB.

 Lincomycin injectable is indicated for the treatment of infectious forms of arthritis caused by organisms sensitive to its activity. This includes most of the organisms responsible for the various infectious arthritides in swine, such as the staphylococci, streptococci, Erysipelothrix and Mycoplasma spp.
It is also indicated for the treatment of mycoplasma pneumonia.

Lincomycin

Lincomycin Injection,Lincomycin Powder,Lincomycin Hydrochloride Powder,Lincomycin Injection For Animal

Hebei Kexing Pharmaceutical Co., Ltd. , https://www.kexingpharmas.com